Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Show more...
首席执行官
Dr. Vidar Wendel-Hansen M.D., Ph.D.
员工
2
国家
SE
ISIN
SE0020678159
WKN
000A3EJG7
上市
0 Comments
分享你的想法
FAQ
Quia Pharma AB 今天的股价是多少?▼
99B0.F 当前价格为 €0 EUR,在过去 24 小时内下跌了 -50%。在图表上更密切关注 Quia Pharma AB 股票的表现。
Quia Pharma AB 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Quia Pharma AB 的股票以代码 99B0.F 进行交易。
Quia Pharma AB 的股价在上涨吗?▼
99B0.F 股票较上周上涨 +0%,本月上涨 +0%,但过去一年 Quia Pharma AB 下跌 -88.89%。